FISH Testing Misses Drug-Targetable EML4-ALK Rearrangements in Lung ...
A team of researchers led by Prof Nir Peled, MD, PhD, at the Davidoff Cancer Center in Petach Tiqwa, Israel, compared the accuracy of FISH and IHC as tools for detecting EML4-ALK rearrangements in lung adenocarcinoma. The team also used genetic ...
PR Web (press release) - Wed, 25 Feb 2015 16:52

Pancreatic adenocarcinoma therapeutics market overview and growth report to ...
Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant', which provides in-depth analysis of pancreatic adenocarcinoma market within the eight major developed markets of the US, UK, France, Germany, Italy, ...
WhaTech - Tue, 17 Feb 2015 18:26



Adenocarcinoma polmonare, pemetrexed più efficace con ALK mutato
I pazienti con adenocarcinoma polmonare portatori di mutazioni del gene della chinasi del linfoma anaplastico (ALK) ottengono un beneficio maggiore dalla terapia a base di pemetrexed rispetto a quelli senza queste mutazioni. A suggerirlo sono i ...
PharmaStar - Sat, 28 Feb 2015 07:37

Genome Sequencing Reveals Four Pancreatic Cancer Subtypes
Through deep sequencing on matched tumor and normal samples from the pancreatic ductal adenocarcinoma patients, Biankin and his colleagues uncovered recurrent within-chromosome rearrangements affecting new and known pancreatic cancer ...
GenomeWeb - Wed, 25 Feb 2015 10:33



Per l'adenocarcinoma del pancreas AIFa approva un farmaco di Celgene
Stiamo parlando di un nuova molecola a base di paclitaxel legato all'albumina formulato in nano particelle, approvato da AIFa per il trattamento in prima linea di pazienti con adenocarcinoma del pancreas metastatico, in combinazione con la gemcitabina.
LiberoQuotidiano.it - Tue, 24 Feb 2015 03:33

Tumore pancreas, rimborsabile nuova terapia in nanoparticelle
La Repubblica - Tue, 24 Feb 2015 03:46

Tumore del pancreas: arriva una nuova arma
PiusaniPiubelli.it - Thu, 26 Feb 2015 01:00

L'Agenzia Italiana del Farmaco ha approvato la rimborsabilità di Abraxane® per ...
insalutenews - Thu, 26 Feb 2015 07:45

Tumore al pancreas, la terapia a base di nanoparticelle diventa rimborsabile
Scienze Fanpage - Tue, 24 Feb 2015 10:17

RECORDS: Births, deaths, bankruptcies
18, 1956, Evansville, hypoxia; gastric internal bleed, Feb. 11. Sawyer, Don Charles; Feb. 23, 1958, Evansville, advanced abdominal adenocarcinoma, Feb. 7. Schmidt, Charles Ernest; Nov. 17, 1935, Evansville, prostate cancer with bone metastases, Jan. 31.
Evansville Courier & Press - Sun, 01 Mar 2015 01:00

AGBT: WashU Applies Genomic Testing to Predict Cancer Relapse, Drug ...
... and have analyzed the data for potential immuno-epitopes, peptides that are most likely to be immunogenic in a vaccine. They plan is to apply a similar approach to patients with triple-negative breast cancer and lung adenocarcinoma, Mardis said.
GenomeWeb - Fri, 27 Feb 2015 07:11

MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis ...
The purpose of this study is to investigate the role of the long noncoding RNA metastasis associated lung adenocarcinoma transcript 2 (MALAT2) in the prognosis of stage II/III gastric cancer (GC) patients. The expression of MALAT2 was evaluated in ...
Nature.com - Fri, 27 Feb 2015 03:31


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014